OMERS Administration Corp’s Dr. Reddy's Laboratories RDY Stock Holding History

OMERS Administration Corp’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$416K	Hold	30,000	–	–	﹤0.01%	790
2025 Q4	$421K	Sell	30,000 -71,300	-70%	-$1M	﹤0.01%	722
2025 Q3	$1.42M	Sell	101,300 -63,235	-38%	-$910K	0.01%	492
2025 Q2	$2.47M	Buy	164,535 +26,300	+19%	+$376K	0.02%	306
2025 Q1	$1.82M	Sell	138,235 -21,300	-13%	-$294K	0.02%	412
2024 Q4	$2.52M	Buy	159,535 +51,300	+47%	+$771K	0.02%	275
2024 Q3	$1.72M	Sell	108,235 -23,000	-18%	-$370K	0.02%	429
2024 Q2	$2M	Buy	131,235 +37,735	+40%	+$541K	0.02%	392
2024 Q1	$1.37M	Sell	93,500 -58,500	-38%	-$854K	0.02%	142
2023 Q4	$2.12M	Buy	+152,000	New	+$2.03M	0.03%	110
2020 Q1	–	Sell	-1,003,500	Closed	-$8.14M	–	345
2019 Q4	$8.14M	Sell	1,003,500 -7,500	-0.7%	-$59.2K	0.09%	124
2019 Q3	$7.66M	Buy	1,011,000 +183,500	+22%	+$1.36M	0.08%	158
2019 Q2	$6.29M	Buy	827,500 +156,000	+23%	+$1.23M	0.07%	162
2019 Q1	$5.64M	Sell	671,500 -93,500	-12%	-$710K	0.06%	90
2018 Q4	$5.77M	Buy	765,000 +64,000	+9%	+$450K	0.08%	70
2018 Q3	$4.85M	Buy	+701,000	New	+$4.68M	0.05%	187

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

OMERS Administration Corp's RDY Position: Q1 2026 in Review

OMERS Administration Corp held its Dr. Reddy's Laboratories (RDY) position steady in Q1 2026 at 30,000 shares worth $416K. The position accounts for ﹤0.01% of the portfolio, ranked #790.

OMERS Administration Corp first reported a position in RDY in Q3 2018 and has held it in 16 quarters since. The position peaked at $8.14M in Q4 2019. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

OMERS Administration Corp held 30,000 shares of Dr. Reddy's Laboratories worth $416K as of Q1 2026.
OMERS Administration Corp left its Dr. Reddy's Laboratories share count unchanged in Q1 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #790 holding.
OMERS Administration Corp first reported a position in Dr. Reddy's Laboratories in Q3 2018 and has held it in 16 quarters since.
OMERS Administration Corp's Dr. Reddy's Laboratories position peaked at $8.14M in Q4 2019.
247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.